Nnamdi Etoh
@Rock Springs Capital Management Lp
Latest period2024 - Q3ReportedManaged Assets$3.074BTotal holdings109
Assets growth rate-7.48%Assets growth rate (2-Q avg)-11.56%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Rock Springs Capital Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 109 positions.
Assets under management
The assets under management (AUM) of Rock Springs Capital Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 3.074B in assets, with a quarterly growth rate of -7.48% and a 2-quarter average growth rate of -11.56%. The portfolio is managed by Nnamdi Etoh, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
KYMRKymera Therapeutics Inc
| 1.62% | $49.667M 1.049M shares@ $47.33 avg price | Decreased -9.84% |
GPCRStructure Therapeutics Inc
| 1.52% | $46.695M 1.064M shares@ $43.9 avg price | Decreased -0.14% |
MRUSMerus N V
| 1.46% | $44.592M 892,549 shares@ $49.96 avg price | Decreased -10.84% |
BSXBoston Scientific Corp
| 1.26% | $38.548M 460,000 shares@ $83.8 avg price | Decreased -43.73% |
CLDXCelldex Therapeutics Inc New
| 1.23% | $37.517M 1.104M shares@ $33.99 avg price | Decreased -21.1% |
PODDInsulet Corp
| 1.02% | $31.189M 134,000 shares@ $232.75 avg price | Decreased -31.28% |
AGIOAgios Pharmaceuticals Inc
| 1.02% | $31.074M 699,389 shares@ $44.43 avg price | Decreased -33.02% |
ALGNAlign Technology Inc
| 0.95% | $29.12M 114,500 shares@ $254.32 avg price | Decreased -10.19% |
AKROAkero Therapeutics Inc
| 0.88% | $26.779M 933,399 shares@ $28.69 avg price | Decreased -13.11% |
AZTAAzenta Inc
| 0.84% | $25.794M 532,500 shares@ $48.44 avg price | Decreased -23.49% |